Prevalence of Endophthalmitis after Intravitreal Injection of Avastin (Bevacizumab) in Patients Wearing Masks
Background and Objective: Although the likelihood of endophthalmitis after intravitreal injection is low, one of the side effects of this injection is blindness. With the prevalence of the COVID-19 pandemic and the necessity of mask use in patients and physicians, mask use has increased. Previous st...
Saved in:
| Main Authors: | A Najafi, F Jafarzade, H Ojaghi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Babol University of Medical Sciences
2024-03-01
|
| Series: | Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Bābul |
| Subjects: | |
| Online Access: | http://jbums.org/article-1-11278-en.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Assessment the microbial contamination rate of re-used vials of bevacizumab(Avastin) and the risk of endophthalmitis.
by: Zainab Taher, et al.
Published: (2025-06-01) -
Endophthalmitis following intravitreal injections at a tertiary center: real-life data on incidence, risk factors, management strategies, and visual outcomes
by: Sebile Comcali, et al.
Published: (2025-05-01) -
The Short-Term Effect of Intravitreal Bevacizumab Injection on Intraocular Pressure
by: Şehnaz Özçalışkan, et al.
Published: (2014-10-01) -
Endophthalmitis following inadvertent intravitreal injection of botulinum toxin: a case report and literature review
by: Saud Mohammed Aljohani, et al.
Published: (2025-07-01) -
Delayed-onset Moraxella nonliquefaciens endophthalmitis following intravitreal injection
by: Paul S. Micevych, et al.
Published: (2025-09-01)